{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:49:48Z","timestamp":1784692188359,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.humpath.2020.07.002","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T21:25:22Z","timestamp":1597181122000},"page":"73-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Chromosome 3p loss of heterozygosity and reduced expression of H3K36me3 correlate with longer relapse-free survival in sacral conventional chordoma"],"prefix":"10.1016","volume":"104","author":[{"given":"Guo Gord","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0982-8122","authenticated-orcid":false,"given":"Chao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0073-0666","authenticated-orcid":false,"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Frosina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Jungbluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ntiamoah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7467-6682","authenticated-orcid":false,"given":"Khedoudja","family":"Nafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2766-243X","authenticated-orcid":false,"given":"Meera R.","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2020.07.002_bib1","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1302\/0301-620X.90B5.20365","article-title":"Dedifferentiated chordoma: a report of four cases arising 'de novo'","volume":"90","author":"Hanna","year":"2008","journal-title":"J Bone Jt Surg Br"},{"key":"10.1016\/j.humpath.2020.07.002_bib2","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1097\/PAS.0b013e31805c9967","article-title":"Intraosseous benign notochord cell tumors (BNCT): further evidence supporting a relationship to chordoma","volume":"31","author":"Deshpande","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2020.07.002_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1470-7330-14-4","article-title":"Difficulty distinguishing benign notochordal cell tumor from chordoma further suggests a link between them","volume":"14","author":"Kreshak","year":"2014","journal-title":"Canc Imag"},{"key":"10.1016\/j.humpath.2020.07.002_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00256-002-0514-z","article-title":"First histologically confirmed case of a classic chordoma arising in a precursor benign notochordal lesion: differential diagnosis of benign and malignant notochordal lesions","volume":"31","author":"Yamaguchi","year":"2002","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.humpath.2020.07.002_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrm3274","article-title":"Understanding the language of Lys36 methylation at histone H3","volume":"13","author":"Wagner","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.humpath.2020.07.002_bib6","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1007\/s00018-017-2517-x","article-title":"Shaping the cellular landscape with Set2\/SETD2 methylation","volume":"74","author":"McDaniel","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.humpath.2020.07.002_bib7","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1158\/0008-5472.CAN-12-4300","article-title":"KDM4\/JMJD2 histone demethylases: epigenetic regulators in cancer cells","volume":"73","author":"Berry","year":"2013","journal-title":"Canc Res"},{"key":"10.1016\/j.humpath.2020.07.002_bib8","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/ng.2814","article-title":"Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone","volume":"45","author":"Behjati","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2020.07.002_bib9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature08672","article-title":"Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes","volume":"463","author":"Dalgliesh","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2020.07.002_bib10","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/ng.2777","article-title":"Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia","volume":"45","author":"Jaffe","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2020.07.002_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/his.13725","article-title":"Histone H3K36M mutation and trimethylation patterns in chondroblastoma","volume":"74","author":"Lu","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2020.07.002_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.3757","article-title":"Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas","volume":"49","author":"Papillon-Cavanagh","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2020.07.002_bib13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/gcc.22362","article-title":"Genomic aberrations frequently alter chromatin regulatory genes in chordoma","volume":"55","author":"Wang","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2020.07.002_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.humpath.2020.07.002_bib15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"issue":"8 Suppl","key":"10.1016\/j.humpath.2020.07.002_bib16","first-page":"4244s","article-title":"Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors","volume":"46","author":"McCarty","year":"1986","journal-title":"Canc Res"},{"key":"10.1016\/j.humpath.2020.07.002_bib17","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cell.2017.10.014","article-title":"Electronic address, e.d.s.c. and N. Cancer Genome Atlas Research, Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas","volume":"171","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2020.07.002_bib18","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/s41467-017-01026-0","article-title":"The driver landscape of sporadic chordoma","volume":"8","author":"Tarpey","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2020.07.002_bib19","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.ccell.2018.03.007","article-title":"Genomic and functional approaches to understanding cancer aneuploidy","volume":"33","author":"Taylor","year":"2018","journal-title":"Canc Cell"},{"key":"10.1016\/j.humpath.2020.07.002_bib20","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2141.2007.06833.x","article-title":"Gene expression profiling of CD34+ cells in patients with the 5q- syndrome","volume":"139","author":"Boultwood","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2020.07.002_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nm.2063","article-title":"A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome","volume":"16","author":"Barlow","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.humpath.2020.07.002_bib22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41576-019-0171-x","article-title":"Context is everything: aneuploidy in cancer","volume":"21","author":"Ben-David","year":"2019","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.humpath.2020.07.002_bib23","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.37294","article-title":"Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death","volume":"7","author":"Hieronymus","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.humpath.2020.07.002_bib24","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2020.07.002_bib25","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1200\/JCO.2005.01.7038","article-title":"Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making","volume":"23","author":"Malcovati","year":"2005","journal-title":"J Clin Oncol"},{"issue":"Suppl 4","key":"10.1016\/j.humpath.2020.07.002_bib26","doi-asserted-by":"crossref","first-page":"i100","DOI":"10.1093\/neuonc\/nos206","article-title":"Personalized care in neuro-oncology coming of age: why we need MGMT and 1p\/19q testing for malignant glioma patients in clinical practice","volume":"14","author":"Weller","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.humpath.2020.07.002_bib27","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1126\/science.aae0065","article-title":"The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas","volume":"352","author":"Fang","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.humpath.2020.07.002_bib28","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/ncb1608","article-title":"NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis","volume":"9","author":"Wang","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.humpath.2020.07.002_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/modpathol.2015.123","article-title":"Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death","volume":"29","author":"Ho","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2020.07.002_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206261","article-title":"Increased Trimethylation of histone H3K36 associates with biliary differentiation and predicts poor prognosis in resectable hepatocellular carcinoma","volume":"13","author":"Lien","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.humpath.2020.07.002_bib31","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.eururo.2012.09.005","article-title":"Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma","volume":"63","author":"Hakimi","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2020.07.002_bib32","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1158\/1078-0432.CCR-12-3886","article-title":"Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network","volume":"19","author":"Hakimi","year":"2013","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.humpath.2020.07.002_bib33","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.juro.2016.06.010","article-title":"Prognostic value of SETD2 expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors","volume":"196","author":"Wang","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2020.07.002_bib34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/1471-2407-9-290","article-title":"The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters","volume":"9","author":"Al Sarakbi","year":"2009","journal-title":"BMC Canc"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720301258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817720301258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:37:40Z","timestamp":1758645460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817720301258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":34,"alternative-id":["S0046817720301258"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2020.07.002","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chromosome 3p loss of heterozygosity and reduced expression of H3K36me3 correlate with longer relapse-free survival in sacral conventional chordoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2020.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}